[HTML][HTML] Clinical Validation of the Myelofibrosis Transplant Scoring System in an Independent Series of Myelofibrosis Patients Undergoing Allogeneic Hematopoietic …
JG Correa, R de la Puerta, A Benzaquen, J Mora… - Blood, 2019 - Elsevier
Introduction: Allogeneic hematopoietic cell transplantation (allo-HCT) constitutes the only
curative treatment for myelofibrosis (MF), but its associated toxicity remains high. Prognostic …
curative treatment for myelofibrosis (MF), but its associated toxicity remains high. Prognostic …
[HTML][HTML] Predicting survival after allogeneic hematopoietic cell transplantation in myelofibrosis: performance of the Myelofibrosis Transplant Scoring System (MTSS) …
JC Hernández-Boluda, A Pereira… - Biology of Blood and …, 2020 - Elsevier
Accurate prognostic tools are crucial to assess the risk/benefit ratio of allogeneic
hematopoietic cell transplantation (allo-HCT) in patients with myelofibrosis (MF). We aimed …
hematopoietic cell transplantation (allo-HCT) in patients with myelofibrosis (MF). We aimed …
Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation
N Gagelmann, M Ditschkowski… - Blood, The Journal …, 2019 - ashpublications.org
Allogeneic hematopoietic stem cell transplantation is curative in myelofibrosis, and current
prognostic scoring systems aim to select patients for transplantation. Here, we aimed to …
prognostic scoring systems aim to select patients for transplantation. Here, we aimed to …
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis
R Tamari, DP McLornan, KW Ahn… - Blood …, 2023 - ashpublications.org
To develop a prognostic model for patients undergoing allogeneic hematopoietic cell
transplantation (allo-HCT) for myelofibrosis (MF), we examined the data of 623 patients …
transplantation (allo-HCT) for myelofibrosis (MF), we examined the data of 623 patients …
[HTML][HTML] Hematopoietic cell transplantation for myelofibrosis: the dynamic international prognostic scoring system plus risk predicts post-transplant outcomes
BTS Bannow, RB Salit, BE Storer, EA Stevens… - Biology of Blood and …, 2018 - Elsevier
Hematopoietic cell transplantation (HCT) provides potentially curative treatment for patients
with myelofibrosis (MF). HCT outcomes are associated with the Dynamic International …
with myelofibrosis (MF). HCT outcomes are associated with the Dynamic International …
Survival advantage to allogeneic transplant in patients with myelofibrosis with intermediate-1 or higher DIPSS score
Introduction: Allogeneic hematopoietic stem cell transplantation (HCT) is the only curative
therapy for myelofibrosis (MF). Consideration of HCT is recommended by international …
therapy for myelofibrosis (MF). Consideration of HCT is recommended by international …
[HTML][HTML] Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic …
M Ditschkowski, AH Elmaagacli, R Trenschel… - …, 2012 - ncbi.nlm.nih.gov
Background Myelofibrosis is a myeloproliferative stem cell disorder curable exclusively by
allogeneic hematopoietic stem cell transplantation and is associated with substantial …
allogeneic hematopoietic stem cell transplantation and is associated with substantial …
Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis
Factors predicting allogeneic hematopoietic cell transplantation (HCT) outcomes in
myelofibrosis in the early post-HCT period have not been defined thus far. We attempt to …
myelofibrosis in the early post-HCT period have not been defined thus far. We attempt to …
Survival following allogeneic transplant in patients with myelofibrosis
Allogeneic hematopoietic cell transplantation (HCT) is the only curative therapy for
myelofibrosis (MF). In this large multicenter retrospective study, overall survival (OS) in MF …
myelofibrosis (MF). In this large multicenter retrospective study, overall survival (OS) in MF …
[HTML][HTML] Hematopoietic cell transplantation for myelofibrosis: dipss plus risk predicts post-transplant outcomes
BTS Bannow, RB Salit, BE Storer… - Biology of blood …, 2017 - pmc.ncbi.nlm.nih.gov
Hematopoietic cell transplantation (HCT) provides potentially curative treatment for patients
with myelofibrosis (MF). HCT outcomes are associated with the Dynamic International …
with myelofibrosis (MF). HCT outcomes are associated with the Dynamic International …
相关搜索
- allogeneic transplant patients with myelofibrosis
- independent series allogeneic hematopoietic transplantation
- clinical validation myelofibrosis patients
- independent series myelofibrosis patients
- independent series clinical validation
- cell transplant clinical factors
- cell transplant survival in patients
- survival in patients clinical factors
- allogeneic transplant survival advantage
- survival advantage patients with myelofibrosis